InvestorsHub Logo
Followers 62
Posts 10251
Boards Moderated 0
Alias Born 06/03/2008

Re: makindatcash post# 145650

Sunday, 03/27/2022 10:17:40 AM

Sunday, March 27, 2022 10:17:40 AM

Post# of 198622
We're going to redefine excellence? True excellence is a successful drug product, not "we're looking into this and it looks good", and not, "We tested it and we think our OWN results are good"! That's "excellence"?

I'm sorry if such a low bar (a single example of a successful DRUG) is too high for this POS company!

You actually want to say an UNPROVEN, UNSOLD product that will never see the light of day in the USA as an approved drug, and has not even entered into a single FDA lab test or any phase, is excellence??? Very pink sheet!

You know what true excellence is?
Rank Drug Main indication Trade name 2018 sales (million USD) 2017 sales (million USD)
1 adalimumab rheumatoid arthritis Humira 19 936 18427
3 apixaban anticoagulant Eliquis 9872 7395
4 lenalidomide multiple myeloma Revlimid 9685 8187
5 nivolumab oncology Opdivo 7570 5763
6 pembrolizumab oncology Keytruda 7171 3809
7 etanercept rheumatoid arthritis Enbrel 7126 7885
8 trastuzumab breast cancer Herceptin 6981 7013
9 bevacizumab colon cancer Avastin 6847 6686
10 rituximab non-Hodgkin's lymphoma Rituxan,
MabThera

6750 7298
11 rivaroxaban anticoagulant Xarelto 6589 6234
12 aflibercept Eylea 6551 5830
13 infliximab Remicade 5908 7152
14 Pneumococcal conjugate vaccine Prevnar 13
Prevenar 13

5802 5601
15 ustekinumab Stelara 5156 4011
16 pregabalin epilepsy Lyrica 4970 506

I assure you, NONE of those successful drugs was created by a company with a CSO that had a revoked medical license (excellence)! LOL